Suggestions
Brian Dhingra
Financing, developing, and commercializing innovative technology Chicago Booth | McKinsey
Brian Dhingra is the Commercialization Lead for Neurodegenerative Disease Diagnostics and Data Platform at Esya Labs.1 He brings a strong background in healthcare strategy and consulting to his role at the company.
Professional Experience
Prior to joining Esya Labs, Brian worked as an Engagement Manager at McKinsey & Company.2 During his time there, he focused on delivering transformative results for clients across the healthcare sector.1 His expertise includes:
- Strategy development
- Corporate finance
- Go-to-market planning
- Mergers and acquisitions (M&A)
Education
Brian is currently pursuing an MBA at the University of Chicago Booth School of Business.2 This educational background complements his professional experience in business strategy and healthcare.
Role at Esya Labs
At Esya Labs, Brian is responsible for leading the commercialization efforts for the company's neurodegenerative disease diagnostics and data platform. Esya Labs operates at the intersection of biochemistry, technology, and medicine, with a particular focus on Alzheimer's disease.1 Brian's role likely involves:
- Developing market entry strategies
- Identifying potential partnerships and collaborations
- Overseeing the go-to-market process for new diagnostic tools
- Analyzing market trends and opportunities in the neurodegenerative disease space
Brian's combination of healthcare sector expertise, strategic thinking, and business acumen makes him well-suited to drive the commercial success of Esya Labs' innovative diagnostic solutions for neurodegenerative diseases.